Description

Cyclohexanecarboxylic Acid, 2-[(2-Pyrimidinylamino)Carbonyl]- (9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its unique bicyclic structure. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities and complex organic syntheses.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the research and synthesis of novel drug candidates, especially for kinase inhibitors and other targeted therapies.
• Organic Synthesis Research: Used in academic and industrial R&D laboratories for constructing complex heterocyclic frameworks and exploring new reaction pathways.
• Agrochemical Development: Acts as a precursor in the design and synthesis of new-generation pesticides and herbicides with specific modes of action.
• Material Science: Potential application in the synthesis of specialty polymers and advanced organic materials requiring specific conformational properties.
• Contract Manufacturing (CMO): Supplied to contract manufacturing organizations for scale-up and cGMP production of clinical trial materials.

Basic Information

Product Name	Cyclohexanecarboxylic Acid, 2-[(2-Pyrimidinylamino)Carbonyl]- (9Ci)
CAS No.	392703-94-5
Molecular Formula	C12H13N3O3
Molecular Weight	247.25 g/mol
Synonyms	2-[(Pyrimidin-2-ylamino)carbonyl]cyclohexanecarboxylic acid; 2-(Pyrimidin-2-ylcarbamoyl)cyclohexanecarboxylic acid; 2-(2-Pyrimidinylaminocarbonyl)cyclohexanecarboxylic Acid; Cyclohexanecarboxylic acid, 2-[[(2-pyrimidinylamino)carbonyl]-; 392703-94-5; 2-(Pyrimidin-2-ylcarbamoyl)cyclohexane-1-carboxylic acid
EINECS	Contact for details

Quality Control

Our production of Cyclohexanecarboxylic Acid, 2-[(2-Pyrimidinylamino)Carbonyl]- (9Ci) adheres to stringent quality management protocols to ensure batch-to-batch consistency and reliability for critical research and development. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We can supply material compliant with various pharmacopeial standards (e.g., USP, EP) for advanced applications, subject to specific customer requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials such as strong oxidizing agents, strong acids, and strong bases. For long-term storage, consider an inert atmosphere to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Water Content (KF)	≤ 0.5% w/w
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.